Literature DB >> 9370049

Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier.

E C de Lange1, M Danhof, A G de Boer, D D Breimer.   

Abstract

For the study of the pharmacokinetics of drugs in the brain a number of in vivo techniques is available, including autoradiography, imaging techniques, cerebrospinal fluid sampling and in vivo voltammetry, which all have their specific advantages and limitations. Intracerebral microdialysis is a relatively new in vivo technique. It permits monitoring of local concentrations of drugs and metabolites at specific sites in the brain which makes it an attractive tool for pharmacokinetic research. In the use of this technique a number of factors should be considered. These include: type of probe, surgical trauma, post-surgery interval, perfusion flow rate, as well as composition and temperature of the perfusion medium. In particular in studies on drug transport across the blood-brain barrier (BBB), effects of insertion of the probe on BBB functionality is important. It appears that BBB functionality is not significantly affected if surgical and experimental conditions are well-controlled. The relationship between dialysate concentrations and those in the extracellular fluid of the periprobe tissue, the recovery of the drug, depends on periprobe processes governing the actual concentration of the drug at that site. These include extracellular-microvascular exchange, metabolism, and diffusion of the drug. Several methods have been proposed to determine recovery values. In particular the no net flux method and the extended no net flux method are useful in practice. Several microdialysis studies on BBB transport of drugs are presented showing that intracerebral microdialysis is capable to assess local BBB transport profiles. Compared with other in vivo techniques, intracerebral microdialysis is the only (affordable) technique that offers the possibility to monitor local BBB transport of drugs in unanaesthetized animals, under physiological and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9370049     DOI: 10.1016/s0165-0173(97)00014-3

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  50 in total

Review 1.  Blood-Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies.

Authors:  Loqman A Mohamed; Shashirekha Markandaiah; Silvia Bonanno; Piera Pasinelli; Davide Trotti
Journal:  AAPS J       Date:  2017-08-04       Impact factor: 4.009

2.  The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study.

Authors:  T H Tsai; S C Liu; P L Tsai; L K Ho; A Y C Shum; C F Chen
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 3.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas.

Authors:  Rachel Grossman; Michelle A Rudek; Harry Brastianos; Patti Zadnik; Henry Brem; Betty Tyler; Jaishri O Blakeley
Journal:  Cancer Chemother Pharmacol       Date:  2012-05-27       Impact factor: 3.333

Review 5.  A review of the effects of FSCV and microdialysis measurements on dopamine release in the surrounding tissue.

Authors:  Andrea Jaquins-Gerstl; Adrian C Michael
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

6.  Population pharmacokinetic analysis for simultaneous determination of B (max) and K (D) in vivo by positron emission tomography.

Authors:  Lia C Liefaard; Bart A Ploeger; Carla F M Molthoff; Ronald Boellaard; Adriaan A Lammertsma; Meindert Danhof; Rob A Voskuyl
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

7.  Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.

Authors:  G Caljon; V Caveliers; T Lahoutte; B Stijlemans; G H Ghassabeh; J Van Den Abbeele; I Smolders; P De Baetselier; Y Michotte; S Muyldermans; S Magez; R Clinckers
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 8.  Pharmacokinetic and metabolism studies using microdialysis sampling.

Authors:  D K Hansen; M I Davies; S M Lunte; C E Lunte
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

9.  A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agent.

Authors:  Jana Portnow; Behnam Badie; Xueli Liu; Paul Frankel; Shu Mi; Mike Chen; Timothy W Synold
Journal:  J Neurooncol       Date:  2014-03-15       Impact factor: 4.130

10.  Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat.

Authors:  Marian Geldof; Jan Freijer; Ludy van Beijsterveldt; Meindert Danhof
Journal:  Pharm Res       Date:  2007-08-21       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.